Anvisa authorizes clinical trial of tetravalent influenza vaccine
The National Health Surveillance Agency (Anvisa) authorized the start of the phase III clinical trial of the tetravalent influenza vaccine, ...
The National Health Surveillance Agency (Anvisa) authorized the start of the phase III clinical trial of the tetravalent influenza vaccine, ...
The Ministry of Health, in partnership with the Ministry of Science, Technology and Innovations and the Ministry of Education, launched ...
Folha Nobre - Desde 2013 - ©